Cargando…
Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812199/ https://www.ncbi.nlm.nih.gov/pubmed/33490208 http://dx.doi.org/10.21037/atm-20-4725 |
| _version_ | 1783637618002493440 |
|---|---|
| author | Alsina, Maria Smyth, Elizabeth C. |
| author_facet | Alsina, Maria Smyth, Elizabeth C. |
| author_sort | Alsina, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7812199 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78121992021-01-22 Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients Alsina, Maria Smyth, Elizabeth C. Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7812199/ /pubmed/33490208 http://dx.doi.org/10.21037/atm-20-4725 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Alsina, Maria Smyth, Elizabeth C. Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title | Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title_full | Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title_fullStr | Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title_full_unstemmed | Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title_short | Safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and S-1 in Japanese gastric cancer patients |
| title_sort | safety and preliminary signs of efficacy with the combination of pembrolizumab plus oxaliplatin and s-1 in japanese gastric cancer patients |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812199/ https://www.ncbi.nlm.nih.gov/pubmed/33490208 http://dx.doi.org/10.21037/atm-20-4725 |
| work_keys_str_mv | AT alsinamaria safetyandpreliminarysignsofefficacywiththecombinationofpembrolizumabplusoxaliplatinands1injapanesegastriccancerpatients AT smythelizabethc safetyandpreliminarysignsofefficacywiththecombinationofpembrolizumabplusoxaliplatinands1injapanesegastriccancerpatients |